Evidence map›Paper›PMID 27245665›Full record

ArticleBMC geriatrics2016

Multi-psychotropic drug prescription and the association to neuropsychiatric symptoms in three Norwegian nursing home cohorts between 2004 and 2011.

Christine Gulla, Geir Selbaek, Elisabeth Flo, Reidun Kjome, Øyvind Kirkevold, Bettina S Husebo

Open access · goldAbstract read
In one paragraph

Article in BMC geriatrics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Christine GullaCentre for Elderly and Nursing Home Medicine, Department of Global Public Health and Primary Care, University of Bergen, PO Box 7804, N-5018, Bergen, Norway. christine.gulla@uib.no.
Geir SelbaekCentre for Old Age Psychiatric Research, Innlandet Hospital Trust, PO Box 2136, N-3103, Tonsberg, Ottestad, Norway.
Elisabeth FloCentre for Elderly and Nursing Home Medicine, Department of Global Public Health and Primary Care, University of Bergen, PO Box 7804, N-5018, Bergen, Norway.
Reidun KjomeResearch group in Social Pharmacy, Department of Global Public Health and Primary Care, and Centre for Pharmacy, University of Bergen, Bergen, Norway.
Øyvind KirkevoldCentre for Old Age Psychiatric Research, Innlandet Hospital Trust, PO Box 2136, N-3103, Tonsberg, Ottestad, Norway.
Bettina S HuseboCentre for Elderly and Nursing Home Medicine, Department of Global Public Health and Primary Care, University of Bergen, PO Box 7804, N-5018, Bergen, Norway.
University of Bergen · NOInnlandet Hospital Trust · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuropsychiatric symptoms, such as affective symptoms, psychosis, agitation, and apathy are common among nursing home patients with and without dementia. Treatment with one or more psychotropic drug is often without explicit clinical indication, despite low treatment efficacy, and potential side effects. We aim to investigate the multi-psychotropic drug use to identify factors and patient characteristics associated with multi-use.

methodsWe analysed three cohorts from 129 Norwegian nursing homes, collected between 2004 and 2011. Patients (N = 4739) were assessed with the Neuropsychiatric Inventory - Nursing Home version (NPI-NH), Clinical Dementia Rating scale, and Physical Self Maintenance Scale. We used ordinal logistic regression to analyse associations between psychotropics (antidepressants, antipsychotics, anxiolytics, hypnotics, and anti-dementia drugs), patient characteristics, and neuropsychiatric symptoms.

resultsPatients used on average 6.6 drugs; 27 % used no psychotropics, 32 % one, and 41 % multiple psychotropic drugs (24 % two, 17 % ≥3). Thirty-nine percent were prescribed antidepressants, 30 % sedatives, 24 % anxiolytics, and 20 % antipsychotics. The total NPI-NH score was associated with multi-use (OR 1.02, 95 % CI 1.02-1.03), and increased from a mean of 13.5 (SD 16.3) for patients using none, to 25.5 (21.8) for patients using ≥3 psychotropics. Affective symptoms (depression and anxiety) were most strongly associated with multi-psychotropic drug use (OR 1.10, 95 % CI: 1.09-1.12). Female gender, independency in daily living, younger age, dementia, and many regular drugs were also associated with multi-use.

conclusionForty-one percent were exposed to multi-psychotropic drug prescriptions. Contrary to current evidence and guidelines, there is an extensive use of multiple psychotropic drugs in patients with severe NPS and dementia.

Indexed as

DementiaPrescription Drug OverusePsychotropic DrugsAgedAged, 80 and overAge FactorsDepressionDrug PrescriptionsFemaleHomes for the AgedHumansMaleNorwayNursing HomesPsychomotor AgitationSex FactorsPsychotropic DrugsAnti-dementia drugsAntidepressantsAntipsychoticsAnxiolyticsDementiaHypnoticsNeuropsychiatric symptomsNursing homesPsychotropic drugs

Identifiers

PMID27245665
PMCPMC4888256
OpenAlexW2411574790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.